Inventor · disambiguated record
Frédéric Gilbert Labéguère
Also filed as: LABEGUERE FREDERIC · LABÉGUÈRE FRÉDÉRIC GILBERT
8 granted patents·4 pending applications·15 citations·filing 2012–2021
80Inventor score
Top patents by PatentIndex Score
12 records- 0185US8927543B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2012·Granted Jan 6, 2015·6 cites·9 claims
- 0284US9255095B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2014·Granted Feb 9, 2016·6 cites·15 claims
- 0379US10047083B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Aug 14, 2018·2 cites·16 claims
- 0474US2022227751A1Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders.GALAPAGOS NV·Filed 2021·Application pending·0 cites
- 0569US9708312B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)GALAPAGOS NV·Filed 2013·Granted Jul 18, 2017·1 cites·17 claims
- 0662US11220499B2Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2018·Granted Jan 11, 2022·0 cites·20 claims
- 0750US2023106420A1Aryl-n-aryl derivatives for treating a rna virus infectionABIVAX·Filed 2020·Application pending·0 cites
- 0846US2018016275A1Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists)GALAPAGOS NV·Filed 2017·Application pending·0 cites
- 0943US2022144823A1Pyrazolopyridine derivatives as inhibitors of paskGALAPAGOS NV·Filed 2020·Application pending·0 cites
- 1038US10829478B25-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Nov 10, 2020·0 cites·37 claims
- 1137US10550100B25-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritisGALAPAGOS NV·Filed 2017·Granted Feb 4, 2020·0 cites·15 claims
- 1237US10508111B26-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitorsGALAPAGOS NV·Filed 2016·Granted Dec 17, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Frédéric Gilbert Labéguère files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →